Home › Funds › Two Sigma Investments › ORMP
Two Sigma Investments position in ORMP
ORAMED PHARMACEUTICALS INC · Health Care
Latest position (Q1 2025)64.42K sh
Reported value held$137.85K
Portfolio Weight0.00%
First reportedQ4 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 402.10K | $5.74M | New |
| Q1 2022 | 550.96K | $4.77M | Add |
| Q2 2022 | 639.56K | $2.93M | Add |
| Q3 2022 | 163.01K | $1.06M | Reduce |
| Q1 2023 | 506.25K | $1.10M | New |
| Q2 2023 | 59.60K | $213.37K | Reduce |
| Q3 2023 | 31.52K | $82.28K | Reduce |
| Q4 2023 | 157.33K | $363.43K | Add |
| Q1 2024 | 134.45K | $392.61K | Reduce |
| Q2 2024 | 150.37K | $386.44K | Add |
| Q3 2024 | 141.68K | $345.71K | Reduce |
| Q4 2024 | 110.38K | $267.12K | Reduce |
| Q1 2025 | 64.42K | $137.85K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ORMP
- BlackRock Inc 1.61M sh · $7.74M · Q2 2026
- Geode Capital Management 500.69K sh · $2.41M · Q2 2026
- Goldman Sachs Group 253.29K sh · $1.22M · Q2 2026
- Northern Trust Corp 184.92K sh · $889.47K · Q2 2026
- Renaissance Technologies 183.80K sh · $884.08K · Q2 2026
- Wells Fargo & Co 166.00K sh · $798.46K · Q2 2026
- Bank of America Corp 150.69K sh · $724.84K · Q2 2026
- Marshall Wace 101.95K sh · $490.39K · Q2 2026
- Charles Schwab Investment Management 83.63K sh · $402.28K · Q2 2026
- BNY Mellon 79.25K sh · $381.22K · Q2 2026
- UBS Group AG 67.67K sh · $325.50K · Q2 2026
- Citadel Advisors 66.56K sh · $320.18K · Q2 2026